Chemical Structure (Gabapentin 01)
Chemical structure of gabapentin showing a cyclohexane ring with amino and acetic acid functional groups attached.*
Gabapentin Tablet, Coated
Product Images NDC 51224-021
7 FDA label images from Tagi Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 51224-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
Line graph showing mean pain score over 8 weeks with baseline, comparing placebo and Gabapentin 3,600 mg/day. The chart indicates a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decrease in mean pain score compared to placebo.*
Figure 2 (Gabapentin 03)
A line graph depicting mean pain scores over a 7-week period, divided into a 3-week dose titration period and a 4-week fixed dose period. The graph compares placebo, Gabapentin 1,800 mg/day, and Gabapentin 2,400 mg/day, showing a decline in mean pain scores for both Gabapentin doses relative to placebo over time.*
Figure 3 (Gabapentin 04)
A bar chart comparing the effects of placebo (PBO) versus Gabapentin (GBP) at different dosages in two studies. The vertical axis shows percentage values up to 100%. Study 1 compares PBO to GBP 3,600 mg, and Study 2 compares PBO to GBP 1,800 mg and 2,400 mg. Statistically significant differences are indicated with asterisks for p-values less than 0.01 and 0.001.*
Figure 4 (Gabapentin 05)
A scatter plot chart comparing difference percentages versus daily doses (mg) ranging from 600 to 1,800 mg. The chart includes data points from three studies labeled as Study a (black squares), Study b (gray squares), and Study c (white squares). The vertical axis represents difference (%) from 2 to 22, and the horizontal axis shows daily doses in mg.*
Principal Display Panel (600 mg Tablet Bottle Label)
Label for Gabapentin Tablets USP 600 mg coated tablets by TAGI Pharma, Inc. The label shows the dosage strength as 600 mg, package size as 100 tablets, and includes storage instructions. It also features the NDC 51224-021-50 and a barcode on the left side.*
Principal Display Panel (800 mg Tablet Bottle Label)
Gabapentin Tablets, USP 800 mg coated oral tablets label. The label indicates packaging of 100 tablets, with instructions for pharmacists to dispense the medication guide separately. It includes storage instructions and is manufactured for TAGI Pharma, Inc. The label features the NDC 51224-121-50 and states 'Rx only'.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
